Bi-heteroaryl substituted 1,4-benzodiazepines and uses thereof for the treatment of cancer

The invention relates to new quinoline, pyridopyrazine, naphthyridine and quinazolinone derivative compounds, to pharmaceutical compositions comprising said compounds, to processes for the preparation of said compounds and to the use of said compounds in the treatment of diseases, e.g. cancer.

Saved in:
Bibliographic Details
Main Authors Querolle, Olivier Alexis Georges, Hostyn, Steven Anna, Jones, Russell Mark, Cuyckens, Filip Albert C, Angibaud, Patrick René, Broggini, Diego Fernando Domenico, Vermeulen, Wim
Format Patent
LanguageEnglish
Published 11.03.2021
Subjects
CHEMISTRY
HETEROCYCLIC COMPOUNDS
HUMAN NECESSITIES
HYGIENE
MEDICAL OR VETERINARY SCIENCE
METALLURGY
ORGANIC CHEMISTRY
PREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES
SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS ORMEDICINAL PREPARATIONS
Online AccessGet full text

Cover

More Information
Summary:The invention relates to new quinoline, pyridopyrazine, naphthyridine and quinazolinone derivative compounds, to pharmaceutical compositions comprising said compounds, to processes for the preparation of said compounds and to the use of said compounds in the treatment of diseases, e.g. cancer.
Bibliography:Application Number: AU20160328693